Stockscreener 앱 받기
18.76
4.43%
-0.87
시장 영업 전:
19.64
0.88
+4.69%
Castle Biosciences Inc 주식(CSTL)의 최신 뉴스
Castle Biosciences, Inc. (NASDAQ:CSTL) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Castle Biosciences CEO Derek Maetzold sells $585,673 in stock - Investing.com India
Major Breakthrough: 10,000-Patient Study Proves Castle's Skin Cancer Tests Save Lives - StockTitan
Castle Biosciences Inc to Host Earnings Call - ACCESS Newswire
Solid Earnings Reflect Castle Biosciences' (NASDAQ:CSTL) Strength As A Business - Yahoo Finance
Castle Biosciences, Inc. (NASDAQ:CSTL) Shares Sold by Rhumbline Advisers - Defense World
CSTL Gears Up to Report Q4 Earnings: Here's What You Should Know - MSN
Castle Biosciences, Inc. (NASDAQ:CSTL) Stock Position Boosted by Truist Financial Corp - Defense World
Leerink Partnrs Weighs in on CSTL Q1 Earnings - Defense World
Castle Biosciences (NASDAQ:CSTL) Price Target Raised to $37.00 - Defense World
Castle Biosciences (NASDAQ:CSTL) Shares Gap Up Following Analyst Upgrade - Defense World
What Is Castle Biosciences, Inc.'s (NASDAQ:CSTL) Share Price Doing? - Yahoo Finance
Castle Biosciences, Inc. (CSTL) Q2 Earnings and Revenues Beat Estimates - MSN
Castle Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Castle Biosciences: Strong Growth Potential and Robust Performance Justify Buy Rating - TipRanks
Castle Biosciences, Inc. (NASDAQ:CSTL) Q4 2024 Earnings Call Transcript - Insider Monkey
Q4 2024 Castle Biosciences Inc Earnings Call - Cbainfo
Castle Biosciences Inc (CSTL) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
Castle Biosciences Reports Strong 2024 Financial Results - TipRanks
Castle Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Castle Biosciences, Inc. (CSTL) Surpasses Q4 Earnings and Revenue Estimates - MSN
Earnings call transcript: Castle Biosciences Q4 2024 sees strong earnings beat - Investing.com
Castle Biosciences Reports Strong 2024 Financial Performance - TipRanks
How Did Castle Biosciences Transform a $57.5M Loss Into $18.2M Profit? 2024 Results Reveal the Answer - StockTitan
What To Expect From Castle Biosciences Inc (CSTL) Q4 2024 Earnin - GuruFocus.com
What To Expect From Castle Biosciences Inc (CSTL) Q4 2024 Earnings - Yahoo Finance
Castle Biosciences to Participate in Upcoming Investor Conferences - The Bakersfield Californian
When Can You Hear From Castle Biosciences Management? Key March Conference Dates Announced - StockTitan
Ligand Leads $75 Million Royalty Financing in Castle Creek Biosciences - GlobeNewswire
Pinning Down Castle Biosciences, Inc.'s (NASDAQ:CSTL) P/S Is Difficult Right Now - Simply Wall St
Castle Biosciences CFO Frank Stokes sells $214,828 in stock By Investing.com - Investing.com Australia
Castle Biosciences CFO Frank Stokes sells $214,828 in stock - Investing.com India
Wall Street Analysts See a 50.79% Upside in Castle Biosciences (CSTL): Can the Stock Really Move This High? - MSN
Castle Biosciences, Inc. (CSTL) Reports Next Week: Wall Street Expects Earnings Growth - MSN
Castle Biosciences (CSTL) Expected to Announce Earnings on Thursday - Defense World
Castle Biosciences director sells $221,636 in stock - MSN
Analysts Set Castle Biosciences, Inc. (NASDAQ:CSTL) Target Price at $40.29 - Defense World
Stephens Inc. AR Trims Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World
Surging Earnings Estimates Signal Upside for Castle Biosciences (CSTL) Stock - MSN
Castle Biosciences to Share Data Reinforcing the Clinical Value of Its Dermatologic Portfolio of Gene Expression Profile Tests at the 22nd Annual Winter Clinical Dermatology ConferenceHawaii® - The Bakersfield Californian
Major Clinical Findings: Castle Bio's Breakthrough Melanoma and Skin Cancer Detection Tests Under Spotlight - StockTitan
Insider Selling: Castle Biosciences, Inc. (NASDAQ:CSTL) Director Sells $221,613.39 in Stock - Armenian Reporter
Castle Biosciences director sells $221,636 in stock By Investing.com - Investing.com Australia
Castle Biosciences to Release Fourth Quarter and Full-Year 2024 Financial Results and Host Conference Call on Thursday, Feb. 27, 2025 - BioSpace
Castle Biosciences Earnings Alert: Key Financial Results Coming Feb 27Here's How to Listen In - StockTitan
1.38%
1.44%
자본화:
|
볼륨(24시간):